Therapeutic Drugs (TDM)
"Our therapeutic drug monitoring proficiency testing scheme - helping your lab to meet measurement challenges"
Therapeutic Drug Monitoring consists of the measurement of specific drug concentrations at timed intervals in patients, usually through blood/serum samples, and is necessary where control of drug concentrations is required to achieve optimum treatment for the patient, or where there is a narrow range between the therapeutic and toxic levels.
TDM, AXIO's Therapeutic Drugs Monitoring proficiency testing programme, provides independent performance assessment for labs undertaking the routine quantification of a wide range of anti-epileptic and other therapeutic drugs.
The operation of the TDM scheme is supported by an Advisory Group consisting of members of professional bodies, scheme participants, and others experienced in the field. The scheme reports on the performance of UK participants (who have clinical responsibilities) to the National Quality Assurance Advisory Panels for Chemical Pathology.
PT Therapeutic Drugs Accreditation
Please see individual products for specific accreditation status See our accreditations

Informazioni sullo schema
Date di distribuzione
Seleziona una categoria
Filtra risultati
- Codice prodotto: PT-TM-PS21
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Paroxetine maleate 0 - 525 µg/L, nmol/L
- Codice prodotto: PT-TM-PS14
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Haloperidol 0 - 70 µg/L, nmol/L
- Codice prodotto: PT-TM-PS27
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Duloxetine 0 - 400 µg/L, nmol/L
- Codice prodotto: PT-TM-AE04
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: Human serum
- Analiti: Perampanel 0 - 1000 mg/L, µmol/L
- Codice prodotto: PT-TM-PS28
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Escitalopram 0 - 350 µg/L, nmol/L
- Codice prodotto: PT-TM-PS29
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Trazodone 0 - 1500 µg/L, nmol/L
- Codice prodotto: PT-TM-AE05
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: Human serum
- Analiti: Brivaracetam 0 - 20 mg/L, µmol/L
- Codice prodotto: PT-TM-PS16
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Perphenazine 0 - 25 µg/L, nmol/L
- Codice prodotto: PT-TM-PS12
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Maprotiline 0 - 450 µg/L, nmol/L
- Codice prodotto: PT-TM-PS22
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Fluvoxamine 0 - 1000 µg/L, nmol/L
- Codice prodotto: PT-TM-PS30
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Sulpiride 0 - 2000 µg/L, nmol/L
- Codice prodotto: PT-TM-PS32
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Mianserin 0 - 1,000 µg/L, nmol/L
- Codice prodotto: PT-TM-PS26
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Ziprasidone 0 - 500 µg/L, nmol/L
- Codice prodotto: PT-TM-PS24
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Amisulpride 0 - 650 µg/L, nmol/L
- Codice prodotto: PT-TM-PS23
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Zuclopenthixol 0 - 125 µg/L, nmol/L
- Codice prodotto: PT-TM-PS13
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Thioridazine 0 - 2000 µg/L, nmol/L
- Codice prodotto: PT-TM-PS07
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: New born calf serum
- Analiti: Fluphenazine 0 - 25 µg/L, nmol/L
- Codice prodotto: PT-TM-TD01
- Schema PT: Therapeutic Drugs (TDM)
- Marca: AXIO
- Matrice: Human serum
- Analiti: Amikacin 0 - 60 mg/L, µmol/L + 20 in più
- 1
- 2
- 3